Predictors of physical activity in hemophilic arthropathy
Part of Blood & lymphatic, Bones, joints & muscles, Genetic & congenital, Mental health, Pain clinical trials.
This study looks at factors that affect physical activity in adults with hemophilia who have joint damage (arthropathy) in their legs. It may help doctors better support patients in staying active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hemophilia A or B
- You are 18 years old or older
- You have a severe form of the disease
- You have joint damage (arthropathy) in your hips, knees, or ankles
- You are on either on-demand or regular preventive (prophylactic) treatment
- You do not use a walker, cane, or wheelchair, and you can manage daily tasks independently
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a structured exercise program helps children with hemophilia A or B safely. It looks at children’s ability to exercise and function, while aiming to avoid complications like leg bleeds or injuries.
This study compares how well children with hemophilia use their arms and hands compared to healthy children. If your child has hemophilia A or B, is on regular treatment, and has no inhibitors or recent bleeds in the arm, they may be able to join.
This trial tests whether an educational program can help patients with hemophilia-related joint damage manage chronic pain better. If you have hemophilia A or B, painful joints, and want to learn new pain coping skills, this study may be a good fit.
This study collects information from people with hemophilia about how treatments and daily life affect them. It uses your answers to improve patient-focused care and understand what challenges matter most.
This trial uses ultrasound to check if healthy joints in people with hemophilia A develop damage while being treated with emicizumab (Hemlibra). It looks at elbows, knees, and ankles over time to see if the medicine prevents joint problems.
This study looks at how prophylactic treatment for hemophilia affects your daily life, sleep, and feelings about your health. It compares different types of clotting factor concentrates to see if one is easier to manage than the other.
Hear when a new Hemophilia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.